By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



9 Bareket st. Kiryat Matalon

  Petach Tikva  49517  Israel
Phone: 972-3-9235556 Fax: 972-3-9235558



Company News
Macrocure (MCUR) Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Curexcell In Diabetic Foot Ulcers 9/2/2014 10:30:21 AM
Macrocure (MCUR) Announces Second Quarter 2014 Financial Results 8/27/2014 7:53:50 AM
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014 7:16:35 AM
Macrocure Selected to Present Scientific Poster at 2013 Symposium on Advanced Wound Care (SAWC) 4/29/2013 11:45:11 AM
Macrocure Nominates Dr. Vickie Driver, President-Elect of the American Association of Advanced Wound Care, as Lead Principal Investigator in Phase III Clinical Trial 4/22/2013 10:49:02 AM
European Patent Office to Grant Patent for Macrocure's CureXcell® 3/21/2013 12:15:58 PM
European Patent Office to Grant Patent for Macrocure's CureXcell® 3/14/2013 10:03:22 AM
Macrocure Taps Ex-Omrix Biopharmaceuticals, Inc. (OMRI) President, Nissim Mashiach as New President & CEO 6/13/2012 7:24:00 AM
Macrocure's CureXcell Shows Strong Efficacy and Safety in Phase IV Hard-To-Heal Wounds Trial 4/30/2012 1:27:32 PM